News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
307,808 Results
Type
Article (16045)
Company Profile (112)
Press Release (291651)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (97374)
Career Advice (732)
Deals (16435)
Drug Delivery (78)
Drug Development (39033)
Employer Resources (96)
FDA (6754)
Job Trends (7118)
News (163641)
Policy (14702)
Tag
Academia (727)
Accelerated approval (2)
Adcomms (6)
Allergies (49)
Alliances (26080)
ALS (46)
Alzheimer's disease (550)
Antibody-drug conjugate (ADC) (53)
Approvals (6787)
Artificial intelligence (199)
Autoimmune disease (13)
Automation (8)
Bankruptcy (152)
Best Places to Work (5184)
BIOSECURE Act (9)
Biosimilars (59)
Biotechnology (49)
Bladder cancer (31)
Brain cancer (18)
Breast cancer (142)
Cancer (941)
Cardiovascular disease (99)
Career advice (644)
Career pathing (32)
CAR-T (34)
Cell therapy (132)
Cervical cancer (6)
Clinical research (32872)
Collaboration (497)
Compensation (185)
Complete response letters (17)
COVID-19 (874)
CRISPR (26)
C-suite (157)
Cystic fibrosis (43)
Data (999)
Decentralized trials (1)
Denatured (46)
Depression (15)
Diabetes (110)
Diagnostics (2295)
Digital health (7)
Diversity (9)
Diversity, equity & inclusion (25)
Drug discovery (71)
Drug pricing (76)
Drug shortages (12)
Duchenne muscular dystrophy (47)
Earnings (34753)
Editorial (18)
Employer branding (13)
Employer resources (81)
Events (44034)
Executive appointments (473)
FDA (7340)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (297)
Gene editing (46)
Generative AI (18)
Gene therapy (137)
GLP-1 (383)
Government (1445)
Grass and pollen (4)
Guidances (77)
Healthcare (5241)
Huntington's disease (5)
IgA nephropathy (14)
Immunology and inflammation (43)
Indications (17)
Infectious disease (925)
Inflammatory bowel disease (70)
Inflation Reduction Act (8)
Influenza (22)
Intellectual property (49)
Interviews (101)
IPO (6445)
IRA (31)
Job creations (2130)
Job search strategy (548)
Kidney cancer (6)
Labor market (39)
Layoffs (204)
Leadership (20)
Legal (3507)
Liver cancer (26)
Lung cancer (113)
Lymphoma (69)
Machine learning (5)
Management (30)
Manufacturing (185)
MASH (46)
Medical device (2286)
Medtech (2289)
Mergers & acquisitions (10243)
Metabolic disorders (342)
Multiple sclerosis (29)
NASH (15)
Neurodegenerative disease (34)
Neuropsychiatric disorders (8)
Neuroscience (802)
NextGen: Class of 2025 (2120)
Non-profit (1084)
Now hiring (39)
Obesity (190)
Opinion (143)
Ovarian cancer (29)
Pain (64)
Pancreatic cancer (26)
Parkinson's disease (59)
Partnered (16)
Patents (138)
Patient recruitment (40)
Peanut (19)
People (32781)
Pharmaceutical (65)
Pharmacy benefit managers (12)
Phase I (8753)
Phase II (13947)
Phase III (12297)
Pipeline (649)
Policy (78)
Postmarket research (1466)
Preclinical (3558)
Press Release (34)
Prostate cancer (61)
Psychedelics (9)
Radiopharmaceuticals (128)
Rare diseases (200)
Real estate (2768)
Recruiting (32)
Regulatory (10697)
Reports (47)
Research institute (882)
Resumes & cover letters (83)
Rett syndrome (2)
RNA editing (2)
RSV (9)
Schizophrenia (45)
Series A (53)
Series B (27)
Service/supplier (5)
Sickle cell disease (34)
Special edition (10)
Spinal muscular atrophy (83)
Sponsored (13)
Startups (1817)
State (2)
Stomach cancer (3)
Supply chain (33)
Tariffs (39)
The Weekly (31)
Vaccines (193)
Venture capitalists (19)
Weight loss (110)
Women's health (21)
Worklife (17)
Date
Today (71)
Last 7 days (435)
Last 30 days (1365)
Last 365 days (14744)
2025 (5507)
2024 (15729)
2023 (17383)
2022 (25312)
2021 (26435)
2020 (24043)
2019 (19001)
2018 (14470)
2017 (15382)
2016 (14561)
2015 (16928)
2014 (13346)
2013 (11255)
2012 (12103)
2011 (12593)
2010 (11378)
Location
Africa (359)
Alabama (16)
Alaska (2)
Arizona (68)
Arkansas (3)
Asia (21602)
Australia (2884)
California (2495)
Canada (1045)
China (272)
Colorado (96)
Connecticut (115)
Delaware (70)
Europe (44808)
Florida (412)
Georgia (61)
Idaho (13)
Illinois (254)
India (18)
Indiana (163)
Iowa (7)
Japan (108)
Kansas (62)
Kentucky (13)
Louisiana (3)
Maine (26)
Maryland (345)
Massachusetts (2002)
Michigan (43)
Minnesota (127)
Missouri (31)
Montana (11)
Nebraska (9)
Nevada (16)
New Hampshire (15)
New Jersey (920)
New Mexico (14)
New York (751)
North Carolina (507)
North Dakota (2)
Northern California (1065)
Ohio (76)
Oklahoma (6)
Oregon (22)
Pennsylvania (562)
Puerto Rico (9)
Rhode Island (13)
South America (549)
South Carolina (4)
South Dakota (1)
Southern California (986)
Tennessee (45)
Texas (362)
United States (9921)
Utah (85)
Virginia (95)
Washington D.C. (36)
Washington State (201)
Wisconsin (26)
307,808 Results for "insight pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Trust, Tech, and Tomorrow: A Pharmaceutical Executive’s WEF Insights
Konstantina Katcheves, Senior VP of Innovative Global Business Development at Teva Pharmaceuticals brings insights from the World Economic Forum to SCOPE 2025.
March 5, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks: Insights into GenScript Biotech Forum 2025
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis talks to Dr. Peter Marks, Director, CBER about his thoughts on the future of cell and gene therapies.
January 16, 2025
·
1 min read
·
Lori Ellis
Business
A Conversation with Peter Marks and Tom Whitehead: Insights into GenScript Biotech Forum 2025 (Teaser)
In this short teaser, BioSpace’s Head of Insights Lori Ellis talks to CBER Director Peter Marks and Tom Whitehead, Co-Founder of the Emily Whitehead Foundation about anticipated discussions at the upcoming GenScript Biotech Forum.
January 10, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH CHARLES RIVER LABORATORIES
Cell and Gene Therapy Sector Sees 30% Investment Surge Despite Market Challenges
Industry updates and investment insights—including investor behavior and fundraising advice—were among the topics experts explored at Charles River Laboratories’ 2025 Cell & Gene Therapy Summit.
March 31, 2025
·
5 min read
·
BioSpace Insights
Drug Development
Eroding Immunity: Vaccine Hesitancy and Cynicism With Paul Offit
In this episode of Denatured BioSpace’s head of insights Lori Ellis discusses the public health consequences of vaccine hesitancy and the critical distinction between skepticism and cynicism with Paul Offit, MD, director of the Vaccine Education Center at the Children’s Hospital of Philadelphia.
May 8, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Economic Challenges, Strategic Investments: Reshaping the Women’s Health Landscape
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses how collaboration and investment shape the the future of women’s health with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 24, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Breaking Down Barriers: The Nuanced Approach to Women’s Representation in Medical Research
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the underrepresentation of women in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
April 10, 2025
·
1 min read
·
Lori Ellis
IN PARTNERSHIP WITH DIA
Balancing Protection and Inclusion: The Evolution of Women in Clinical Trials
In this episode presented by DIA, BioSpace’s head of insights Lori Ellis discusses the evolution of women’s inclusion in clinical trials with Martin Hodosi, partner at Kearney and Melissa Laitner, director of strategic initiatives at the National Academy of Medicine.
March 27, 2025
·
1 min read
·
Lori Ellis
Business
Navigating Patient Journeys with Tom Whitehead
In this episode, presented by the Genscript Biotech Global Forum 2025, BioSpace’s Head of Insights Lori Ellis and Tom Whitehead continue to discuss the patient and caregiver experience, where Tom gives his insights to the future of CGTs.
February 13, 2025
·
1 min read
·
Lori Ellis
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
·
1 min read
·
Lori Ellis
1 of 30,781
Next
